AR067830A1 - Proteinas streptococcus inmunogenicas - Google Patents

Proteinas streptococcus inmunogenicas

Info

Publication number
AR067830A1
AR067830A1 ARP080103446A ARP080103446A AR067830A1 AR 067830 A1 AR067830 A1 AR 067830A1 AR P080103446 A ARP080103446 A AR P080103446A AR P080103446 A ARP080103446 A AR P080103446A AR 067830 A1 AR067830 A1 AR 067830A1
Authority
AR
Argentina
Prior art keywords
proteins
immunogenic
streptococcus
producing
immune response
Prior art date
Application number
ARP080103446A
Other languages
English (en)
Spanish (es)
Inventor
Hilda Elizabeth Smith
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of AR067830A1 publication Critical patent/AR067830A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
ARP080103446A 2007-08-06 2008-08-07 Proteinas streptococcus inmunogenicas AR067830A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07113844A EP2023143A1 (en) 2007-08-06 2007-08-06 Immunogenic streptococcus proteins

Publications (1)

Publication Number Publication Date
AR067830A1 true AR067830A1 (es) 2009-10-21

Family

ID=38890252

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080103446A AR067830A1 (es) 2007-08-06 2008-08-07 Proteinas streptococcus inmunogenicas

Country Status (19)

Country Link
US (1) US20100297183A1 (OSRAM)
EP (3) EP2023143A1 (OSRAM)
JP (2) JP5462164B2 (OSRAM)
KR (1) KR20100063706A (OSRAM)
CN (1) CN101821627A (OSRAM)
AR (1) AR067830A1 (OSRAM)
AU (1) AU2008284491A1 (OSRAM)
BR (1) BRPI0815604A2 (OSRAM)
CA (1) CA2695721A1 (OSRAM)
CL (1) CL2008002320A1 (OSRAM)
CO (1) CO6270172A2 (OSRAM)
DK (1) DK2183597T3 (OSRAM)
ES (1) ES2432407T3 (OSRAM)
MX (1) MX2010001482A (OSRAM)
RU (1) RU2518315C2 (OSRAM)
TW (1) TW200911999A (OSRAM)
UA (1) UA103885C2 (OSRAM)
WO (1) WO2009020391A1 (OSRAM)
ZA (1) ZA201000806B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1098980B1 (en) 1998-07-22 2014-09-03 Stichting Dienst Landbouwkundig Onderzoek Streptococcus suis vaccines and diagnostic tests
ATE507238T1 (de) * 2001-02-02 2011-05-15 Stichting Dienst Landbouwkundi Umwelt-regulierte gene, welche an der virulenz von streptococcus suis beteiligt sind
GB0818231D0 (en) 2008-10-06 2008-11-12 Univ Nottingham Composition
WO2015042369A2 (en) * 2013-09-19 2015-03-26 Zoetis Llc Oil-based adjuvants
US20170369529A1 (en) * 2014-12-22 2017-12-28 Hoffmann-La Roche Inc. Cell penetrating peptides
CA3001433A1 (en) 2015-10-21 2017-04-27 Minervax Aps Immunogenic fusion protein
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
RU2685957C2 (ru) * 2016-12-28 2019-04-23 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Химерный рекомбинантный белок, обладающий протективными свойствами в отношении Streptococcus pyogenes
CA3196872A1 (en) * 2020-12-23 2022-06-30 Chan Zuckerberg Biohub, Inc. Bacteria-engineered to elicit antigen-specific t cells
CN112773891B (zh) * 2021-02-01 2022-03-25 北部湾大学 卵形鲳鲹源无乳链球菌dna疫苗及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283507A (en) 1990-12-20 1994-02-01 General Electric Company Regenerative braking protection for an electrically-propelled traction vehicle
NL9100510A (nl) * 1991-03-21 1992-10-16 Centraal Diergeneeskundig Inst Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens.
IT1251435B (it) 1991-09-04 1995-05-09 Sclavo Spa Vettore genetico per la integrazione multipla stabile di sequenze di dna nel genoma dei lieviti kluyveromyces lactis e saccharomyces cerevisiae e plasmidi che lo contengono.
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
EP0804582A1 (en) * 1994-05-16 1997-11-05 The Uab Research Foundation $i(STREPTOCOCCUS PNEUMONIAE) CAPSULAR POLYSACCHARIDE GENES AND FLANKING REGIONS
US5681570A (en) * 1995-01-12 1997-10-28 Connaught Laboratories Limited Immunogenic conjugate molecules
EP0750042A1 (fr) * 1995-06-20 1996-12-27 Societe Des Produits Nestle S.A. Bactéries lactiques produisant des exopolysaccharides
AU738649B2 (en) 1996-04-26 2001-09-20 Rijksuniversiteit Te Leiden Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
EP1098980B1 (en) * 1998-07-22 2014-09-03 Stichting Dienst Landbouwkundig Onderzoek Streptococcus suis vaccines and diagnostic tests
US6582706B1 (en) * 1998-12-21 2003-06-24 Medimmune, Inc. Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS
WO2000077178A1 (en) * 1999-06-16 2000-12-21 Boston Biomedical Research Institute IMMUNOLOGICAL CONTROL OF β-AMYLOID LEVELS IN VIVO
DE60136356D1 (de) * 2000-06-12 2008-12-11 Univ Saskatchewan Chimäres GapC Protein aus Streptococcus und dessen Verwendung zur Impfung und Diagnostik
EP1205552A1 (en) * 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Virulence of streptococci, involving ORFs from Streptococcus suis
ATE507238T1 (de) * 2001-02-02 2011-05-15 Stichting Dienst Landbouwkundi Umwelt-regulierte gene, welche an der virulenz von streptococcus suis beteiligt sind
BR0316635A (pt) * 2002-11-26 2005-10-11 Univ Tennessee Res Foundation Molécula de aderência de streptococcus uberis
EP1590368B1 (en) * 2003-01-27 2014-02-26 Københavns Universitet Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
US20080175856A1 (en) * 2003-05-30 2008-07-24 Intercell Ag Enterococcus Antigens
WO2006048763A1 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
SI2029173T1 (sl) * 2006-06-26 2016-12-30 Macrogenics, Inc. Protitelesa, specifična za Fc RIIB, in postopki za njihovo uporabo

Also Published As

Publication number Publication date
UA103885C2 (en) 2013-12-10
BRPI0815604A2 (pt) 2015-03-03
RU2518315C2 (ru) 2014-06-10
EP2023143A1 (en) 2009-02-11
MX2010001482A (es) 2010-03-01
EP2660604A2 (en) 2013-11-06
CN101821627A (zh) 2010-09-01
JP2010535500A (ja) 2010-11-25
CA2695721A1 (en) 2009-02-12
KR20100063706A (ko) 2010-06-11
US20100297183A1 (en) 2010-11-25
DK2183597T3 (da) 2013-10-14
JP5462164B2 (ja) 2014-04-02
EP2183597A1 (en) 2010-05-12
TW200911999A (en) 2009-03-16
ZA201000806B (en) 2010-10-27
CO6270172A2 (es) 2011-04-20
EP2183597B1 (en) 2013-07-24
ES2432407T3 (es) 2013-12-03
RU2010107878A (ru) 2011-09-20
JP2014095721A (ja) 2014-05-22
WO2009020391A1 (en) 2009-02-12
CL2008002320A1 (es) 2009-09-25
AU2008284491A1 (en) 2009-02-12
EP2660604A3 (en) 2014-02-12

Similar Documents

Publication Publication Date Title
AR067830A1 (es) Proteinas streptococcus inmunogenicas
BRPI0614761A2 (pt) proteìnas de fusão de albumina
ES2563646T3 (es) Composiciones y métodos relacionados con variantes de la proteína A (SpA)
BR112013032764A2 (pt) misturador estático para tratamento de gases de exaustão e método de fabricação do mesmo
MX358725B (es) Antigenos prostaticos de consenso, molecula de acido nucleico que los codifica y vacuna y usos que los comprenden.
BR112014027128A2 (pt) antígenos associados à próstata e regimes de imunoterapia baseada em vacina
BR112023005674A2 (pt) Construtos anti-cd93 e usos dos mesmos
BR112016002614A8 (pt) Imunocitoquina, ácido nucleico, vetor, célula hospedeira e composição farmacêutica
BRPI1010830A2 (pt) Sequências de aminoácidos melhoradas direcionadas contra o vírus respiratório sencicial humano (hrsv) e polipetídeos que compreende os mesmos para prevenção e/ou tratamento de infecções do trato respiratório.
BR112019006388A2 (pt) enzimas modificadoras de ácido nucleico guiadas por rna e métodos de uso das mesmas
BRPI0806578A8 (pt) Promotores de lactococcus e usos dos mesmos
BRPI0707154B8 (pt) composição de vacina
BR112012024964A2 (pt) anticorpo de cadeia única bioespecífico psmaxcd3 de espécies cruzadas específicas, seu processso de preparação, seu uso, vetor, composição farmacêutica e kit
BR112012009289A2 (pt) isolamento e purificação de anticorpos anti-il-13 com uso de cromatografia de afinidade com proteína a.
BR112012029588A2 (pt) materiais biológicas relacionados a her3.
BR112022024629A2 (pt) Construtos anti-cd93 e seus usos
BR112015013387B8 (pt) Proteínas tipo coiled-coil modificadas possuindo propriedades melhoradas
BRPI0821034A8 (pt) Vírus influenza b recombinante, seu uso, metodo de preparação, composição de vacina o contendo e seu gene m, bem como ácido nucléico isolado, molécula do vírus influenza m e seu uso e método para aumentar a taxa de crescimento de vírus influenza b deficiente de replicação
WO2021202734A3 (en) Universal influenza vaccine using nucleoside-modifield mrna
BR112014018884A2 (pt) antígenos amplamente reativos computacionalmente otimizados para viroses de influenza h3n2, h2n2, e b
BR112012028893A2 (pt) composições imunoestimuladoras e de vacina
BR112015032556A2 (pt) Proteína matriz (m) modificada de um vírus da estomatite vesicular (vsv); sequência de nucleotídeos que codifica uma proteína matriz modificada de um vírus da estomatite vesicular; vírus da estomatite vesicular recombinante (rvsv); vacina; vacina de combinação de preparação e reforço; kit; peptídeo isolado; sequências de nucleotídeos isoladas; uso da vacina; uso da vacina de combinação de preparação e reforço; método para induzir uma resposta imunológica em um indivíduo
MX2015011487A (es) Proteinas de consenso para el virus de la enfermedad de la fiebre aftosa (fmdv), secuencias de codificacion para estas y vacunas elaboradas a partir de estas.
BR112018075513A2 (pt) ácidos nucleicos que codificam as partículas seme-lhantes ao vírus da zika e seu uso nas vacinas e no ensaio de diagnóstico do vírus da zika
WO2012149160A3 (en) Viruses modified with unnatural moieties and methods of use thereof

Legal Events

Date Code Title Description
FB Suspension of granting procedure